Published in Gastroenterology on June 01, 1987
Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis. Gut (1996) 2.40
Cancer surveillance in patients with primary sclerosing cholangitis. Hepatology (2011) 2.01
Complications and risk factors after ileal pouch-anal anastomosis for ulcerative colitis associated with primary sclerosing cholangitis. Ann Surg (1993) 1.63
Classification, diagnosis, and management of cholangiocarcinoma. Clin Gastroenterol Hepatol (2012) 1.55
Waitlist survival of patients with primary sclerosing cholangitis in the model for end-stage liver disease era. Liver Transpl (2011) 1.37
Efficacy of hepatic transplantation in patients with primary sclerosing cholangitis. Surg Gynecol Obstet (1993) 1.21
Current trends in living donor liver transplantation for primary sclerosing cholangitis. Transplantation (2011) 1.19
Primary sclerosing cholangitis. Can J Gastroenterol (2008) 1.17
Aetiology and natural history of primary sclerosing cholangitis--a decade of progress? Gut (1991) 1.02
Resection of hepatic duct bifurcation and transhepatic stenting for sclerosing cholangitis. Ann Surg (1988) 0.97
Ulcerative colitis disease activity as subjectively assessed by patient-completed questionnaires following orthotopic liver transplantation for sclerosing cholangitis. Dig Dis Sci (1991) 0.97
Ulcerative colitis disease activity following treatment of associated primary sclerosing cholangitis with cyclosporin. Gut (1993) 0.90
Primary sclerosing cholangitis: outcome of patients undergoing restorative proctocolecetomy for ulcerative colitis. Int J Colorectal Dis (2009) 0.81
Sclerosing cholangitis and biliary tract calculi--primary or secondary? Gut (1992) 0.81
Sclerosing cholangitis associated with Crohn's disease and autoimmune haemolytic anaemia. Postgrad Med J (1993) 0.79
Serum albumin predicts survival in patients with hilar cholangiocarcinoma. Gastroenterol Rep (Oxf) (2016) 0.78
Primary sclerosing cholangitis--approach to diagnosis. MedGenMed (2007) 0.75
Characteristic Findings of Primary Sclerosing Cholangitis on Endoscopic Retrograde Cholangiography: Which is the Most Common Finding? Clin Med Insights Gastroenterol (2011) 0.75
Detection of Autoantibodies to Vascular Endothelial Growth Factor Receptor-3 in Bile Duct Ligated Rats and Correlations with a Panel of Traditional Markers of Liver Diseases. Dis Markers (2016) 0.75
Improving biliary-enteric drainage in primary sclerosing cholangitis: experience with endoscopic methods. Gut (1991) 0.75
Primary Sclerosing Cholangitis: Current and Future Management Strategies. Curr Hepat Rep (2013) 0.75
Asymptomatic primary sclerosing cholangitis with marked hepatic fibrosis. Dig Dis Sci (2000) 0.75
Interaction of murine ets-1 with GGA-binding sites establishes the ETS domain as a new DNA-binding motif. Genes Dev (1992) 3.69
Molecular pathogenesis of cholestasis. N Engl J Med (1998) 2.68
Structural and functional polarity of canalicular and basolateral plasma membrane vesicles isolated in high yield from rat liver. J Cell Biol (1984) 2.47
Significance of retroperitoneal air after endoscopic retrograde cholangiopancreatography with sphincterotomy. Am J Gastroenterol (1999) 2.37
Specificity within the ets family of transcription factors. Adv Cancer Res (1998) 2.21
Second messenger cascade specificity and pharmacological selectivity of the human P2Y1-purinoceptor. Br J Pharmacol (1996) 2.12
Comparative biochemistry of non-muscle actins. J Biol Chem (1977) 1.92
Outpatient liver biopsy: how safe is it? Ann Intern Med (1993) 1.90
Phosphoinositide hydrolysis by guanosine 5'-[gamma-thio]triphosphate-activated phospholipase C of turkey erythrocyte membranes. Biochem J (1988) 1.88
Synthesis, biological activity, and molecular modeling of ribose-modified deoxyadenosine bisphosphate analogues as P2Y(1) receptor ligands. J Med Chem (2000) 1.85
Characterization of the cooperative function of inhibitory sequences in Ets-1. Mol Cell Biol (1996) 1.85
Identification of potent, selective P2Y-purinoceptor agonists: structure-activity relationships for 2-thioether derivatives of adenosine 5'-triphosphate. J Med Chem (1993) 1.84
P2-purinergic receptors: subtype-associated signaling responses and structure. Annu Rev Pharmacol Toxicol (1995) 1.84
The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis. Gastroenterology (1997) 1.83
Isolated rat hepatocyte couplets: a primary secretory unit for electrophysiologic studies of bile secretory function. Proc Natl Acad Sci U S A (1984) 1.77
Expression of a cloned P2Y purinergic receptor that couples to phospholipase C. Mol Pharmacol (1994) 1.76
Peliosis hepatis associated with androgenic-anabolic steroid therapy. A severe form of hepatic injury. Ann Intern Med (1974) 1.75
Agonist action of adenosine triphosphates at the human P2Y1 receptor. Mol Pharmacol (1998) 1.74
Mechanisms and regulation of bile secretion. Hepatology (1991) 1.74
The prognostic importance of clinical and histologic features in asymptomatic and symptomatic primary biliary cirrhosis. N Engl J Med (1983) 1.67
Deoxyadenosine bisphosphate derivatives as potent antagonists at P2Y1 receptors. J Med Chem (1998) 1.61
Human P2Y1 receptor: molecular modeling and site-directed mutagenesis as tools to identify agonist and antagonist recognition sites. J Med Chem (1998) 1.61
Hepatic injury from chronic hypervitaminosis a resulting in portal hypertension and ascites. N Engl J Med (1974) 1.58
Exercise therapy in hypertensive men. JAMA (1970) 1.58
Caspase-3 controls both cytoplasmic and nuclear events associated with Fas-mediated apoptosis in vivo. Proc Natl Acad Sci U S A (1998) 1.56
Cytochemical localization of Na+, K+-ATPase in the rat hepatocyte. J Clin Invest (1978) 1.54
Idiopathic portal hypertension. Comparison with the portal hypertension of cirrhosis and extrahepatic portal vein obstruction. Ann Intern Med (1967) 1.51
Effect of UDCA on intracellular and biliary pH in isolated rat hepatocyte couplets and perfused livers. Am J Physiol (1991) 1.51
Pattern of necrosis in acute viral hepatitis. Prognostic value of bridging (subacute hepatic necrosis). N Engl J Med (1970) 1.50
Canalicular bile formation in the isolated perfused rat liver. Am J Physiol (1971) 1.43
Solution structure of the ETS domain from murine Ets-1: a winged helix-turn-helix DNA binding motif. EMBO J (1996) 1.36
Isolated rat hepatocyte couplets in short-term culture: structural characteristics and plasma membrane reorganization. Hepatology (1987) 1.35
Acyclic and cyclopropyl analogues of adenosine bisphosphate antagonists of the P2Y1 receptor: structure-activity relationships and receptor docking. J Med Chem (2001) 1.32
Purification and characterization of a new recombinant factor VIII (N8). Haemophilia (2009) 1.31
Ultrastructural changes in livers of two patients with hypervitaminosis A. Am J Pathol (1974) 1.29
Cellular mechanisms of bile formation. Gastroenterology (1982) 1.28
Comparison of vitamin D and 25-hydroxy-vitamin-D in the therapy of primary biliary cirrhosis. Lancet (1976) 1.27
The clinical importance of a protein-bound fraction of serum bilirubin in patients with hyperbilirubinemia. N Engl J Med (1983) 1.26
Expression cloning of two genes that together mediate organic solute and steroid transport in the liver of a marine vertebrate. Proc Natl Acad Sci U S A (2001) 1.26
Canalicular bile flow and bile secretory pressure. Evidence for a non-bile salt dependent fraction in the isolated perfused rat liver. Gastroenterology (1970) 1.26
The Comparative Toxicogenomics Database (CTD): a resource for comparative toxicological studies. J Exp Zool A Comp Exp Biol (2006) 1.25
Structural integrity of hepatocyte tight junctions. J Cell Biol (1983) 1.25
Structure-activity relationships of bisphosphate nucleotide derivatives as P2Y1 receptor antagonists and partial agonists. J Med Chem (1999) 1.25
Adaptive regulation of bile salt transporters in kidney and liver in obstructive cholestasis in the rat. Gastroenterology (2001) 1.24
Mechanisms of taurocholate transport in canalicular and basolateral rat liver plasma membrane vesicles. Evidence for an electrogenic canalicular organic anion carrier. J Biol Chem (1984) 1.22
A comparison of maximal oxygen uptake by treadmill and step-test procedures. J Appl Physiol (1966) 1.22
Down-regulation of expression and function of the rat liver Na+/bile acid cotransporter in extrahepatic cholestasis. Gastroenterology (1996) 1.21
Endotoxin downregulates rat hepatic ntcp gene expression via decreased activity of critical transcription factors. J Clin Invest (1998) 1.21
Direct determination of the driving forces for taurocholate uptake into rat liver plasma membrane vesicles. J Clin Invest (1983) 1.19
Characterization of cytosolic Ca2+ signaling in rat bile duct epithelia. Am J Physiol (1996) 1.18
Quantitative assessment of canalicular bile formation in isolated hepatocyte couplets using microscopic optical planimetry. J Clin Invest (1989) 1.18
Purification of an AlF4- and G-protein beta gamma-subunit-regulated phospholipase C-activating protein. J Biol Chem (1991) 1.17
Cellular localization and up-regulation of multidrug resistance-associated protein 3 in hepatocytes and cholangiocytes during obstructive cholestasis in rat liver. Hepatology (2001) 1.16
New concepts of mechanisms of hepatocyte bile formation. Physiol Rev (1980) 1.16
Cyclic AMP stimulates sorting of the canalicular organic anion transporter (Mrp2/cMoat) to the apical domain in hepatocyte couplets. J Cell Sci (1998) 1.16
Chronic hepatitis--a perspective on classification and determinants of prognosis. Gastroenterology (1976) 1.16
Intracellular pH regulation in isolated rat bile duct epithelial cells. J Clin Invest (1991) 1.15
Integrins regulate the linkage between upstream and downstream events in G protein-coupled receptor signaling to mitogen-activated protein kinase. J Biol Chem (2000) 1.14
Isolation of small polarized bile duct units. Proc Natl Acad Sci U S A (1995) 1.14
Cardiovascular changes with age and exercise. A 28-year longitudinal study. Scand J Med Sci Sports (1995) 1.13
Effect of secretion on intracellular pH regulation in isolated rat bile duct epithelial cells. J Clin Invest (1993) 1.13
Phalloidin-induced cholestasis: a microfilament-mediated change in junctional complex permeability. Proc Natl Acad Sci U S A (1980) 1.13
Swelling-activated anion conductance in skate hepatocytes: regulation by cell Cl- and ATP. Am J Physiol (1996) 1.13
Structural coupling of the inhibitory regions flanking the ETS domain of murine Ets-1. Protein Sci (1996) 1.13
Na-H exchange regulates intracellular pH in isolated rat hepatocyte couplets. Am J Physiol (1987) 1.12
Structure-activity relationships of pyridoxal phosphate derivatives as potent and selective antagonists of P2X1 receptors. J Med Chem (2001) 1.12
Nonalcoholic liver disease. Overlooked causes of liver injury in patients with heavy alcohol consumption. Am J Med (1979) 1.10
Secondary structure of the ETS domain places murine Ets-1 in the superfamily of winged helix-turn-helix DNA-binding proteins. Biochemistry (1994) 1.10
Properties of (Na+ plus K+)-activated ATPase in rat liver plasma membranes enriched with bile canaliculi. Biochim Biophys Acta (1975) 1.10
Promoting comparative molecular studies in environmental health research: an overview of the comparative toxicogenomics database (CTD). Pharmacogenomics J (2004) 1.10
Expression of the bile salt export pump is maintained after chronic cholestasis in the rat. Gastroenterology (2000) 1.10
Functional expression of a cDNA encoding a human ecto-ATPase. Br J Pharmacol (1999) 1.09
Fidelity in functional coupling of the rat P2Y1 receptor to phospholipase C. Br J Pharmacol (1997) 1.08
Acyclic analogues of deoxyadenosine 3',5'-bisphosphates as P2Y(1) receptor antagonists. J Med Chem (2000) 1.08
Laboratory and clinical studies of a new antibiotic, cephaloglycin in the treatment of urinary tract infections. Yale J Biol Med (1968) 1.08
The effect of thyroid hormone on bile salt-independent bile flow and Na+, K+ -ATPase activity in liver plasma membranes enriched in bile canaliculi. J Clin Invest (1976) 1.07
Stimulation of thymidine incorporation in mouse liver and biliary tract epithelium by lithocholate and deoxycholate. Gastroenterology (1978) 1.07
Bile formation in the rat: the role of the paracellular shunt pathway. J Clin Invest (1978) 1.07
Effects of osmotic stresses on isolated rat hepatocytes. I. Ionic mechanisms of cell volume regulation. Am J Physiol (1990) 1.06
Ursodeoxycholic acid in cholestasis: potential mechanisms of action and therapeutic applications. Hepatology (1998) 1.06
Bicarbonate-dependent and -independent intracellular pH regulatory mechanisms in rat hepatocytes. Evidence for Na+-HCO3- cotransport. J Clin Invest (1989) 1.05
Preparation and specific applications of isolated hepatocyte couplets. Methods Enzymol (1990) 1.05
2-thioether 5'-O-(1-thiotriphosphate)adenosine derivatives as new insulin secretagogues acting through P2Y-Receptors. J Med Chem (1999) 1.05
Aminopyrine N-demethylation: a prognostic test of liver function in patients with alcoholic liver disease. Gastroenterology (1980) 1.05
Serum hormone levels following partial hepatectomy in the rat. Biochem Biophys Res Commun (1975) 1.04
Cell membrane and transepithelial voltages and resistances in isolated rat hepatocyte couplets. J Membr Biol (1987) 1.04
Asymptomatic primary biliary cirrhosis. A progress report on long-term follow-up and natural history. Gastroenterology (1985) 1.03
Tauroursodeoxycholic acid stimulates hepatocellular exocytosis and mobilizes extracellular Ca++ mechanisms defective in cholestasis. J Clin Invest (1993) 1.03
Evidence for carrier-mediated chloride/bicarbonate exchange in canalicular rat liver plasma membrane vesicles. J Clin Invest (1985) 1.03
Tauroursodeoxycholic acid activates protein kinase C in isolated rat hepatocytes. Gastroenterology (1996) 1.03
A pyridoxine cyclic phosphate and its 6-azoaryl derivative selectively potentiate and antagonize activation of P2X1 receptors. J Med Chem (1998) 1.02
Gastrointestinal neurofibromatosis. J Clin Gastroenterol (1984) 1.02
Biliary secretion in elasmobranchs. II. Hepatic uptake and biliary excretion of organic anions. Am J Physiol (1976) 1.02
Glucose reabsorption from bile. Evidence for a biliohepatic circulation. J Clin Invest (1974) 1.02
Intrahepatic portal vein occlusion. A cause of portal hypertension. Radiology (1969) 1.01
Cl(-)-HCO3- exchanger in isolated rat hepatocytes: role in regulation of intracellular pH. Am J Physiol (1991) 1.00
DBcAMP stimulates vesicle transport and HRP excretion in isolated perfused rat liver. Am J Physiol (1990) 1.00
Effects of Ca2+ agonists on cytosolic Ca2+ in isolated hepatocytes and on bile secretion in the isolated perfused rat liver. Hepatology (1992) 1.00
Hyperammonemic coma due to parenteral nutrition in a woman with heterozygous ornithine transcarbamylase deficiency. Gastroenterology (1995) 1.00